Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Neurologia (Engl Ed) ; 38(1): 41-46, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36167285

RESUMO

INTRODUCTION: Neurological diseases are the leading cause of disability and the second leading cause of death worldwide. Physical and psychological pain, despair, and disconnection with the environment are observed after the diagnosis of numerous neurological processes, particularly neurodegenerative diseases. DEVELOPMENT: A higher risk of suicide is observed in patients with such common neurological diseases as epilepsy, migraine, and multiple sclerosis, as well as in those with such degenerative disorders as Alzheimer disease, Huntington disease, amyotrophic lateral sclerosis, and Parkinson's disease. In most cases, suicidal ideation appears in the early stages after diagnosis, in the presence of disabling symptoms, and/or in patients with psychiatric comorbidities (often associated with these neurological diseases). CONCLUSIONS: Effective suicide prevention in this population group requires assessment of the risk of suicide mainly in newly diagnosed patients, in patients showing unmistakable despair or disabling symptoms, and in patients presenting psychiatric comorbidities (especially depressive symptoms). It is essential to train specialists to detect warning signs in order that they may adopt a suitable approach and determine when psychiatric assessment is required.


Assuntos
Epilepsia , Doença de Parkinson , Suicídio , Humanos , Suicídio/psicologia , Ideação Suicida , Prevenção do Suicídio , Doença de Parkinson/psicologia , Epilepsia/psicologia
2.
Neurologia (Engl Ed) ; 2020 Jun 22.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32586697

RESUMO

INTRODUCTION: Neurological diseases are the leading cause of disability and the second leading cause of death worldwide. Physical and psychological pain, despair, and disconnection with the environment are observed after the diagnosis of numerous neurological processes, particularly neurodegenerative diseases. DEVELOPMENT: A higher risk of suicide is observed in patients with such common neurological diseases as epilepsy, migraine, and multiple sclerosis, as well as in those with such degenerative disorders as Alzheimer disease, Huntington disease, amyotrophic lateral sclerosis, and Parkinson's disease. In most cases, suicidal ideation appears in the early stages after diagnosis, in the presence of disabling symptoms, and/or in patients with psychiatric comorbidities (often associated with these neurological diseases). CONCLUSIONS: Effective suicide prevention in this population group requires assessment of the risk of suicide mainly in newly diagnosed patients, in patients showing unmistakable despair or disabling symptoms, and in patients presenting psychiatric comorbidities (especially depressive symptoms). It is essential to train specialists to detect warning signs in order that they may adopt a suitable approach and determine when psychiatric assessment is required.

3.
Trans R Soc Trop Med Hyg ; 86(2): 141-8, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1440772

RESUMO

Between 1975 and 1987, epidemiological studies were carried out in several rural and urban communities in the central part of western Venezuela, especially in the state of Lara. 115 positive cultures were obtained from human cases and identified by their reactivity patterns to a cross-panel of specific monoclonal antibodies using a radioimmune binding assay; 53 were Leishmania venezuelensis and 62 were L. braziliensis. Most of these stocks were also characterized by isoenzyme electrophoresis, which confirmed the identification of the L. venezuelensis isolates. The enzyme electrophoretic profiles of the L. braziliensis isolates, however, revealed two populations with distinct electromorphs, one related to the World Health Organization L. braziliensis reference strain while the other population appeared to be a hybrid between L. braziliensis and L. guyanensis. L. braziliensis variants showed the widest geographical distribution, and were found in 7 states: Districto Federal (Caracas); Lara (Barquisimeto, Crespo, Iribarren, Jimenez, Morán, Palavecino, Torres, Urdaneta); Nueva Esparta (Margarita); Portuguesa (Las Cruces, Rio Amarillo); Trujillo (Cuicas); Yaracuy (Agua Fria, Cambural, Guaremal); and Zulia (Zipa-Yare). L. venezuelensis was found in the following endemic regions: Lara (Barquisimeto, Iribarren, Jimenez, Morán); Merida (Zéa); and Yaracuy (Campos Elias), showing that this parasite has a much wider geographical distribution than was initially recognized and that both these species can occur simultaneously within the same endemic region. Five isolates of L. braziliensis were made from infected donkeys (Equus asinus) in Urdaneta, Lara State, suggesting a possible domestic reservoir of L. braziliensis.


Assuntos
Leishmania/isolamento & purificação , Leishmaniose Cutânea/parasitologia , Adolescente , Adulto , Idoso , Animais , Anticorpos Monoclonais/imunologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Leishmania/classificação , Leishmania braziliensis/classificação , Leishmania braziliensis/isolamento & purificação , Leishmaniose Cutânea/epidemiologia , Masculino , Pessoa de Meia-Idade , Venezuela/epidemiologia
4.
Brain Res Bull ; 10(5): 597-601, 1983 May.
Artigo em Inglês | MEDLINE | ID: mdl-6347344

RESUMO

We have devised techniques with which to detect specific proteins as well as mRNAs in individual cells of the nervous system. We have localized proteins to specific cells in sections of the neonatal rat cerebellum by immunofluorescence and in the same cells have localized mRNAs by in situ hybridization. The specific protein identified was glial fibrillary acidic protein. The [3H] complementary DNA probes used in the in situ hybridization experiments were synthesized using as templates polyadenylated mRNAs isolated from neonatal rat cerebellum. Such dual detection can be used to assess the cellular sites of synthesis of the many proteins that have been localized in brain and other tissues by immunohistochemistry.


Assuntos
Encéfalo/metabolismo , Proteínas do Tecido Nervoso/metabolismo , RNA Mensageiro/metabolismo , Animais , Cerebelo/metabolismo , DNA/metabolismo , Imunofluorescência , Proteína Glial Fibrilar Ácida , Proteínas de Filamentos Intermediários/metabolismo , Neurônios/metabolismo , Ratos , Ratos Endogâmicos F344
5.
Rev Neurol ; 32(1): 18-21, 2001.
Artigo em Espanhol | MEDLINE | ID: mdl-11293093

RESUMO

INTRODUCTION: Anterior ischemia optic neuropathy is defined as ischemia of the disc optic papilla nerve. The aetiology is multifactorial and causes ischemia of the optic disc and apoptosis of the nerve cells of the retina. OBJECTIVE: To study the retina of patients with anterior ischemia optic neuropathy by means of the electroretinogram pattern (PERG) to assess the function of ganglion cells of the inner layers of the retina. PATIENTS AND METHODS: We studied 12 patients referred from the Ophthalmology Department with the diagnosis of anterior ischemia optic neuropathy. The electrophysiological study consisted of PERG and PEV within 20 days of the episode. The latencies and amplitudes of the different components of the responses and the ratios of the PERG amplitudes were determined. RESULTS: No significant differences were seen in the P50 component of the PERG or the latency of the N95 component. However, statistically significant values were obtained for the amplitude N95. These differences were greater when measured from a nonlinear baseline. CONCLUSIONS: The PERG is useful for early diagnosis of patients with anterior ischaemia optic neuropathy. Measurement of the N95 is more useful when a nonlinear baseline is used. This shows dysfunction of the ganglion cells of the inner retina caused by ischaemia and retrograde degeneration of axons and cell bodies of the optic nerve.


Assuntos
Eletrorretinografia , Isquemia/fisiopatologia , Disco Óptico/irrigação sanguínea , Nervo Óptico/irrigação sanguínea , Idoso , Diagnóstico Diferencial , Potenciais Evocados Visuais , Feminino , Humanos , Isquemia/diagnóstico , Masculino , Pessoa de Meia-Idade , Nervo Óptico/fisiopatologia , Neurite Óptica/diagnóstico , Tempo de Reação , Células Ganglionares da Retina/fisiologia , Degeneração Retrógrada
7.
J Cell Biochem ; 27(3): 205-14, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-2859294

RESUMO

It has been shown by in vitro translation of polyadenylated messenger RNAs (poly(A)+ mRNAs) that the mRNAs encoding both alpha and beta tubulin isotypes are present at much higher relative levels in the developing rat brain than they are in the adult, suggesting that the requirements for tubulin subunits vary with cell type and/or with the developmental stages of a particular cell type. The postnatally developing rat cerebellum, with its readily identifiable cell populations that perform the gamut of developmental tasks, is a suitable model for analyzing specific cellular mRNA distributions during development. In this report, by in situ hybridization techniques it is shown that, by comparison to total cellular poly(A)+ mRNA levels, there is relatively more of the total beta tubulin mRNAs in mitotically active external granule layer cells than in those in the internal granule layer. These results show that migration and differentiation of these granule cells is accompanied by a decrease in their beta tubulin mRNA levels relative to the levels in granule cells of the external granule cell layer. Furthermore, the relative levels of beta tubulin mRNA both in the prenatally formed Purkinje cells and the postnatally formed stellate cells are two to fourfold less than in the granule cells of the internal granule cell layer.


Assuntos
Cerebelo/crescimento & desenvolvimento , RNA Mensageiro/metabolismo , Tubulina (Proteína)/genética , Animais , Cerebelo/citologia , Cerebelo/metabolismo , Hibridização de Ácido Nucleico , Poli A/metabolismo , Células de Purkinje/metabolismo , Ratos
8.
Int J Dermatol ; 35(8): 561-5, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8854152

RESUMO

BACKGROUND: While studying cutaneous leishmaniasis in the central part of western Venezuela, we found four cases of disseminated American cutaneous leishmaniasis, three from the Lara State and one from Portuguesa State. METHODS: A clinical history was taken for each of these patients, followed by microscopic examination of the Giemsastained smears from their cutaneous lesions and by a Montenegro skin test. Serum from a skin lesion were grown in Novy-MacNeal-Nicolle medium (NNN). Hamsters were inoculated with suspension of tissues taken from the patient's lesions. Biopsies were taken for histopathologic examination. Isolates from cultures on NNN medium and from hamsters were subcultured in Schneider's medium for parasite identification, using molecular techniques. Treatment with injections of N-methyl glucamine antimonate, 25 mg/kg/day was prescribed for each patient for 20 consecutive days and, after a week of rest, a second course of injections was administered. RESULTS: Patients had disseminated papular, ulcerous, nodular, and ulceronodular lesions on the skin. Smears of the skin lesions from all of the patients showed abundant amastigotes within histiocytes or free in the tissues. The skin test was negative in two patients. On histopathologic examination of skin lesions, mainly numerous vacuolated histiocytes filled with amastigotes were observed. Isolates from all the patients were identified as Leishmania venezuelensis. One of the patients healed after treatment with N-methyl glucamine antimonate. The others were resistant to this therapy. CONCLUSIONS: Diffuse cutaneous leishmaniasis can be caused also by Leishmania venezuelensis. Patients with nodular lesions who presented a negative Montenegro skin test were more resistant to treatment with specific pentavalent antimonials.


Assuntos
Leishmania/classificação , Leishmaniose Cutânea/diagnóstico , Adolescente , Adulto , Animais , Antimônio/administração & dosagem , Antimônio/uso terapêutico , Antiprotozoários/administração & dosagem , Antiprotozoários/uso terapêutico , Corantes Azur , Biópsia , Criança , Cricetinae , Meios de Cultura , Citodiagnóstico , Esquema de Medicação , Resistência a Medicamentos , Feminino , Histiócitos/parasitologia , Humanos , Injeções Intradérmicas , Leishmania/isolamento & purificação , Leishmaniose Cutânea/tratamento farmacológico , Leishmaniose Cutânea/patologia , Masculino , Meglumina/administração & dosagem , Meglumina/uso terapêutico , Antimoniato de Meglumina , Pessoa de Meia-Idade , Compostos Organometálicos/administração & dosagem , Compostos Organometálicos/uso terapêutico , Testes Cutâneos , Úlcera Cutânea/parasitologia , Venezuela
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA